Data from Restylane Shaype^TM – the first-and-only hyaluronic acid (HA) shaper developed with novel NASHA-HD™ technology as well as expanded indications for Restylane Lyft^TM and Restylane Volyme^TM* are being presented with clinical evidence in the chin, jawline, temples, and lower face.² Across four studies, Restylane delivered well-tolerated, effective, and long-lasting aesthetic improvements in multiple facial regions, consistently achieving high responder rates and high subject satisfaction.² Additionally, addressing the growing demand for body rejuvenation, data evaluating the effectiveness and safety of Restylane Skinboosters for correction of moderate-to-severe wrinkles in the décolletage will be shared at the congress, noting that the product was well tolerated and highly efficacious, with high patient satisfaction.³ In a dedicated symposium, international experts will discuss best practices for use of Galderma’s Injectable Aesthetics portfolio for the body through the AART™ (Assessment, Anatomy, Range, and Treatment) of Body – a patient-centric technique to evaluate needs and create structured individualized treatment plans. Content will highlight the UAE expanded indications for Sculptra in the gluteal area, posterior thighs, and décolletage.⁹ The symposium will take place Thursday, October 22, from 11:00 AM – 1:00 PM GST, in Baniyas ballroom 1.